| Pharmaceutical active ingredients: |
| DexamethasoneTrichlormethiazide |
| Available forms, composition and doses of Naquasone: |
| Injectable; Injection; Dexamethasone 0.5 mg; Trichlormethiazide 10 mg / ml |
| Naquasone medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C03AA06 - TrichlormethiazideH02AB02 - Dexamethasone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bayer Schering PharmaIntervetSchering-Plough |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Naptizer | Cuminum Cyminum; Foeniculum Vulgare; Piper Longum; Tinospora Cordifolia | Baroda Pharmaceutical |
| Napton | Chlordiazepoxide | Unidentified Pharmaceutical Company |
| Napxen | Naproxen | Merck; Berlin Pharmaceutical Industry |
| Naqua | Trichlormethiazide | Bayer Schering Pharma |
| Naqua | Furosemide | Bial Laboratorios |
| Naquasone Bolus | Dexamethasone; Trichlormethiazide | Bayer; Intervet |
| Naquinto | Bromoform; Homatropine; Sodium Dibunate | Makros Industria Farmaceutica |
| Naquival | Reserpine; Trichlormethiazide | Bayer Schering Pharma; Schering-Plough |
| Naragran | Naratriptan Hydrochloride | GlaxoSmithKline |
| Naramig | Naratriptan Hydrochloride | GlaxoSmithKline; Schwarz Pharma; Zuellig Pharma |